Clinical Trials on Infant Health Risk Factors in Belgium

Total 47 results

Universitaire Ziekenhuizen KU Leuven

Completed

Augmented Renal Clearance in the Adult Non-critically Ill Surgery Patient: a Prospective Point Prevalance Study (ARCPPS)

Prevalence of Augmented Renal Clearance | Risk Factors for Augmented Renal Clearance

Belgium
University of Oxford
British Heart Foundation; European Commission; Oxford University Hospitals NHS... and other collaborators

Recruiting

The Oxford Risk Factors And Non-Invasive Imaging Study (ORFAN)

Cardiovascular Diseases | Cardiovascular Risk Factors

United Kingdom, Germany, Belgium, China, United States, Australia, France, Greece, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Romania, United Arab Emirates
Université Libre de Bruxelles

Completed

Comparison of Electronic Cigarettes and Tobacco Cigarettes on Cardiovascular Function and Oxidative Stress

Cardiovascular Risk Factor

Belgium
University Ghent

Completed

Relationship Between Footwear Consumer Behaviour and Lower Extremity Injuries

Sports Injury | Risk Factor | Footwear

Belgium
Hasselt University

Unknown

Chronotropic Incompetence During Exercise Testing in Obese Adolescents

Obesity, Childhood | Cardiovascular Risk Factor | Cardiac Disease

Belgium
Universitair Ziekenhuis Brussel

Active, not recruiting

Low Grade Inflammation in Childhood Obesity : an Independent Risk Factor for Endothelial Dysfunction

Inflammation | Obesity | Endothelial Dysfunction | Obesity, Childhood | Cardiovascular Risk Factor

Belgium
Eindhoven University of Technology

Completed

Evaluation of the Impact of Adaptive Goal Setting on Engagement Levels of Government Staff With a Gamified mHealth Tool (BSAK19)

Lifestyle | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, Sedentary

Belgium
Erasme University Hospital

Terminated

Minimally Invasive Detection of a Sleep Apnoea (KCG_SLEEP)

Cardiovascular Diseases | Cardiovascular Risk Factor | Sleep Disorder; Breathing-Related | Cardiovascular Complication

Belgium
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

CANVAS - CANagliflozin cardioVascular Assessment Study (CANVAS)

Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk Factors

United States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
AstraZeneca

Completed

European Study of Cardiovascular Risk (EURIKA)

Smoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Cardiovascular Risk Factors

Sweden, France, Russian Federation, Spain, Turkey, United Kingdom, Germany, Norway, Austria, Belgium, Switzerland, Greece
Société des Produits Nestlé (SPN)

Active, not recruiting

Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s) (CLARA)

Healthy Infants

France, Belgium, Germany, Spain
Gabi SmartCare

Completed

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study) (BRIDGE)

Cardiovascular Diseases | Respiratory Disease | Cardiac Disease | Congenital Cardiac Defect | Premature Infant Disease | Chronic Respiratory Disease | Chronic Cardiopulmonary Disease

United States, Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Comparison of Amikacin Lung Delivery With Two Nebulizers

Healthy | Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Evaluation of Nebulization and Positive Expiratory Pressure Combination

Cystic Fibrosis | Healthy Subjects

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults

Healthy | Cystic Fibrosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children

Healthy | Cystic Fibrosis

Belgium
Universitair Ziekenhuis Brussel

Completed

Sonographic QUantification of Venous Circulation In the Preterm Brain (SQUIB)

Intraventricular Hemorrhage | Prematurity; Extreme | Periventricular Leukomalacia | Cerebral Circulatory Failure

Belgium
Universitaire Ziekenhuizen KU Leuven
B. Braun Medical SA

Completed

PREMO Study: to Investigate Port REMoval Outcomes (PREMO)

Neoplasms | Cystic Fibrosis

Belgium
University Hospital, Ghent

Completed

Quality of Life 1y and 2 y After VV-ECMO for COVID-19

Quality of Life | Death | Extracorporeal Membrane Oxygenation Complication | COVID-19 Acute Respiratory Distress Syndrome

Belgium
Universitaire Ziekenhuizen KU Leuven
BEDAL; Remedus

Terminated

Impact of Availability of Showerpatch for Patients With Intravenous Catheters (ISIC)

Neoplasms | Cystic Fibrosis | Pulmonary Hypertension

Belgium
Medtronic BRC

Completed

Reveal® XT Performance Trial (XPECT)

Atrial Fibrillation | Risk of Cardiac Arrhythmias

Netherlands, Germany, Austria, Belgium, Canada, Czech Republic, Russian Federation, Slovakia
Universitaire Ziekenhuizen KU Leuven

Completed

Vaccination Coverage and Level of Protection in Patients at Risk

Diabetes | Allergy | Chronic Kidney Disease | Cystic Fibrosis | Heart Disease

Belgium
Clinical Hospital Centre Zagreb
European Society of Hypertension

Unknown

Blood Pressure Control in ESH Excellence Centres (BP-CON)

White Coat Hypertension | Blood Pressure | Lifestyle Risk Reduction

Israel, Greece, Belgium, Germany, Armenia, Austria, Bulgaria, Croatia, Czechia, Estonia, Italy, Lebanon, Lithuania, Netherlands, Poland, Portugal, Romania, Serbia, Spain, Sweden, Ukraine, United Kingdom
Sanofi
Bristol-Myers Squibb

Terminated

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

Atrial Fibrillation | Vascular Risk

United States, France, Canada, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Denmark, Finland, H... and more
Sanofi
Bristol-Myers Squibb

Completed

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Atrial Fibrillation | Vascular Risk

United States, France, Canada, Brazil, Poland, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finland, Hungary, Norway, United... and more
Nemours Children's Clinic
Thomas Jefferson University; Thrasher Research Fund; Jawaharlal Nehru Medical... and other collaborators

Not yet recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries- PreTerm (CORDMILK-PT)

Infant Death | Preterm

India
Bioverativ, a Sanofi company

Completed

A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A (XTEND-1)

Factor VIII Deficiency

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
NICHD Global Network for Women's and Children's...

Completed

First Breath: Neonatal Resuscitation in Developing Countries

Asphyxia Neonatorum

Argentina, Guatemala, Congo, India, Pakistan, Zambia
PedNet Haemophilia Research Foundation
Lund University Hospital

Recruiting

The European Paediatric Network for Haemophilia Management ( PedNet Registry) (PedNet)

Factor IX Deficiency | Factor VIII Deficiency

Norway, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors (HAVEN 6)

Hemophilia A | Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor | Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor

United States, Netherlands, Belgium, France, Germany, South Africa, Spain, Canada, United Kingdom, Poland
Nemours Children's Clinic
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up (CORDMILK-FU)

Hypoxic-Ischemic Encephalopathy | Birth Asphyxia

India
Nemours Children's Clinic
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries (CORDMILK)

Hypoxic-Ischemic Encephalopathy | Birth Asphyxia

India
Boston Scientific Corporation

Completed

Registry on WATCHMAN Outcomes in Real-Life Utilization (EWOLUTION)

Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke

Ireland, Spain, Germany, Netherlands, France, United Kingdom, Italy, Russian Federation, Portugal, Belgium, Poland, Saudi Arabia, United Arab Emirates
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Ablynx, a Sanofi company

Completed

Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

Unstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)

Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia
Paragonix Technologies

Enrolling by invitation

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs (GUARDIANLUNG)

Emphysema | Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Cystic Fibrosis | Interstitial Lung Disease | COPD

United States, Belgium
University Hospital Tuebingen
Oslo University Hospital; University of Zurich; KU Leuven; UMC Utrecht; University... and other collaborators

Recruiting

Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome (ALBINO)

Infant, Newborn, Diseases | Encephalopathy, Hypoxic-Ischemic

Netherlands, Germany, Belgium, Austria, Estonia, Finland, Italy, Norway, Spain, Switzerland, Poland, Portugal
Janssen Research & Development, LLC

Completed

A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma

High-risk Smoldering Multiple Myeloma

United States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
Actelion

Terminated

Persistent Pulmonary Hypertension of the Newborn (FUTURE 4)

Persistent Pulmonary Hypertension of the Newborn

United States, Australia, Belgium, Czech Republic, France, Germany, Korea, Republic of, Poland, Russian Federation, Singapore, Switzerland, United Kingdom
AstraZeneca

Completed

Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention (PANDORA)

Peripheral Arterial Disease (PAD) | Moderate Risk for Cardiovascular Disease (CVD)

France, Netherlands, Switzerland, Greece, Belgium, Italy
AstraZeneca
The Cleveland Clinic; IQVIA RDS Inc.

Completed

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH)

Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
Proteostasis Therapeutics, Inc.

Completed

Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis

Healthy Volunteer - Complete | Cystic Fibrosis - Complete

United States, Belgium, United Kingdom, France, Germany, Canada, Denmark, New Zealand, Australia
Centre Hospitalier Universitaire de Liege
Sanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaborators

Recruiting

Baby Detect : Genomic Newborn Screening

Congenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditions

Belgium
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Pulmonary Hypertension, Familial Persistent, of the Newborn

United States, Belgium, United Kingdom, Spain, Denmark, Germany, Sweden, Canada, France, Italy, Netherlands, Norway
AstraZeneca
Bristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study Group

Completed

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)

Diabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular Event

United States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
Novo Nordisk A/S

Recruiting

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (ZEUS)

Inflammation | Chronic Kidney Disease | Cardiovascular Risk

Korea, Republic of, Italy, United States, Spain, China, Taiwan, Mexico, Netherlands, Latvia, Malaysia, Thailand, Hungary, Australia, Poland, South Africa, India, Canada, Portugal, Romania, United Kingdom, Bulgaria, Germany, Brazil, Sw... and more
Bayer

Recruiting

A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke (OCEANIC-STROKE)

Acute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic Attack

United States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more

Clinical Trials on Infant Health Risk Factors in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations